Marburg Virus Disease Pipeline Offers Promising New Options for Treatment
Bavarian Nordic, BioCryst Pharmaceuticals, Integrated Biotherapeutics, Geovax, Batavia Biosciences, Globavir Biosciences, Collaboration Pharmaceuticals, Emergex Vaccines, ReiThera, Emergent BioSolutions, Mapp Biopharmaceuticals, Biofactura, Alkido Pharma, Flow Pharma, and others are developing potential drug candidates to improve the Marburg Virus Disease treatment scenario. BioCryst is developing galidesivir in partnership with U.S. government agencies and other institutions. In September ...
United States Shruti Thakur Los Angeles Alkido Pharma Globavir Biosciences University Collaborations Licensing Partnering Analysis
Source: benzinga.com